We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"... medullary thyroid carcinoma, and anaplastic thyroid carcinoma, each characterized by distinct mutations governing cellular proliferation. In ..."
"It is not for people with a personal or family history of medullary thyroid carcinoma, or with the genetic condition MEN 2. Warning signs include ..."
"... thyroid cancers and 25% of medullary thyroid cancers. In patients presenting with a new thyroid malignancy, recognition of an underlying ..."
"Selpercatinib is a selective, orally bioavailable small-molecular inhibitor of the "rearranged during transfection" (RET) receptor tyrosine kinase."
"Oral GLP-1 therapy requires strict fasting administration, specific kidney function thresholds, and absence of medullary thyroid cancer history."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.